Latest Insider Transactions at Insmed Inc (INSM)
This section provides a real-time view of insider transactions for Insmed Inc (INSM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of INSMED Inc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of INSMED Inc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 11
2025
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
99,172
-13.36%
|
$9,222,996
$93.88 P/Share
|
|
Jun 11
2025
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
70,000
+27.07%
|
$910,000
$13.91 P/Share
|
|
Jun 11
2025
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
19,423
-18.94%
|
$1,825,762
$94.5 P/Share
|
|
Jun 11
2025
|
Martina M.D. Flammer Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,423
+15.93%
|
$330,191
$17.07 P/Share
|
|
Jun 10
2025
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
38,300
-24.41%
|
$3,370,400
$88.64 P/Share
|
|
Jun 10
2025
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
38,300
+19.62%
|
$651,100
$17.16 P/Share
|
|
Jun 10
2025
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
25,740
-23.65%
|
$2,265,120
$88.64 P/Share
|
|
Jun 10
2025
|
Martina M.D. Flammer Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,740
+19.12%
|
$669,240
$26.46 P/Share
|
|
Jun 10
2025
|
Sara Bonstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
57,766
-7.0%
|
$5,141,174
$89.47 P/Share
|
|
Jun 10
2025
|
Sara Bonstein Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
47,890
+13.89%
|
$862,020
$18.01 P/Share
|
|
Jun 05
2025
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,879
-2.7%
|
$137,167
$73.5 P/Share
|
|
Jun 04
2025
|
David W J Mcgirr Director |
SELL
Open market or private sale
|
Direct |
3,000
-2.98%
|
$219,000
$73.27 P/Share
|
|
Jun 03
2025
|
Sara Bonstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,579
-1.37%
|
$112,109
$71.5 P/Share
|
|
Jun 03
2025
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,860
-1.3%
|
$132,060
$71.5 P/Share
|
|
Jun 03
2025
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,686
-1.99%
|
$119,706
$71.5 P/Share
|
|
Jun 03
2025
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,448
-2.04%
|
$102,808
$71.5 P/Share
|
|
Jun 03
2025
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
5,472
-1.74%
|
$388,512
$71.5 P/Share
|
|
Jun 03
2025
|
David W J Mcgirr Director |
SELL
Open market or private sale
|
Direct |
3,250
-3.13%
|
$230,750
$71.3 P/Share
|
|
Jun 03
2025
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
1,642
-1.37%
|
$116,582
$71.5 P/Share
|
|
Jun 02
2025
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Indirect |
6,830
-0.95%
|
$484,930
$71.17 P/Share
|
|
Jun 02
2025
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
6,830
+2.76%
|
$68,300
$10.85 P/Share
|
|
May 30
2025
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
26,327
-14.23%
|
$1,816,563
$69.28 P/Share
|
|
May 27
2025
|
Melvin Md Sharoky Director |
SELL
Bona fide gift
|
Direct |
200
-0.07%
|
-
|
|
May 21
2025
|
Clarissa Desjardins Director |
BUY
Open market or private purchase
|
Indirect |
1,130
+27.2%
|
$74,580
$66.35 P/Share
|
|
May 20
2025
|
Clarissa Desjardins Director |
BUY
Open market or private purchase
|
Indirect |
1,895
+50.0%
|
$125,070
$66.87 P/Share
|
|
May 20
2025
|
Melvin Md Sharoky Director |
BUY
Bona fide gift
|
Indirect |
400
+50.0%
|
-
|
|
May 20
2025
|
Melvin Md Sharoky Director |
SELL
Bona fide gift
|
Direct |
400
-0.13%
|
-
|
|
May 20
2025
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Indirect |
6,830
-0.95%
|
$457,610
$67.86 P/Share
|
|
May 20
2025
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
6,830
+2.76%
|
$68,300
$10.85 P/Share
|
|
May 20
2025
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
21,057
-2.14%
|
$1,410,819
$67.77 P/Share
|
|
May 16
2025
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,799
-2.08%
|
$120,533
$67.53 P/Share
|
|
May 15
2025
|
Michael Alexander Smith Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,578
+5.42%
|
-
|
|
May 15
2025
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
9,925
-10.28%
|
$645,125
$65.47 P/Share
|
|
May 15
2025
|
Martina M.D. Flammer Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,508
+6.32%
|
-
|
|
May 15
2025
|
William Lewis Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
22,314
+6.24%
|
-
|
|
May 15
2025
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,578
+4.43%
|
-
|
|
May 15
2025
|
Roger Adsett Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,508
+4.35%
|
-
|
|
May 15
2025
|
Sara Bonstein Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,508
+5.36%
|
-
|
|
May 15
2025
|
Leo Lee Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,058
+3.75%
|
-
|
|
May 15
2025
|
David W J Mcgirr Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,058
+4.64%
|
-
|
|
May 15
2025
|
Elizabeth M Anderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,058
+6.42%
|
-
|
|
May 15
2025
|
Melvin Md Sharoky Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,058
+1.65%
|
-
|
|
May 15
2025
|
Clarissa Desjardins Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,058
+7.02%
|
-
|
|
May 15
2025
|
Carol Schafer Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,058
+7.4%
|
-
|
|
May 15
2025
|
David R Brennan Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,058
+3.83%
|
-
|
|
May 14
2025
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
1,236
-1.07%
|
$80,340
$65.61 P/Share
|
|
May 14
2025
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
409
-0.44%
|
$26,585
$65.61 P/Share
|
|
May 14
2025
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,744
-1.9%
|
$113,360
$65.61 P/Share
|
|
May 14
2025
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
3,771
-1.19%
|
$245,115
$65.61 P/Share
|
|
May 14
2025
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,925
-1.39%
|
$125,125
$65.61 P/Share
|